Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.216 USD | +3.10% | +4.10% | -85.50% |
Apr. 16 | Barnes & Noble Education to Receive $95 Million Investment, Adopts Short-Term Poison Pill; Shares Plunge | MT |
Apr. 16 | Barnes & Noble Education Adopts Short-Term Poison Pill | MT |
Financials (USD)
Sales 2024 * | 1.58B | Sales 2025 * | 1.62B | Capitalization | 11.48M |
---|---|---|---|---|---|
Net income 2024 * | -56M | Net income 2025 * | -19M | EV / Sales 2024 * | 0.01 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.01 x |
P/E ratio 2024 * |
-0.2
x | P/E ratio 2025 * |
-0.58
x | Employees | 3,450 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.73% |
Latest transcript on Barnes & Noble Education, Inc.
1 day | +3.10% | ||
1 week | +4.10% | ||
Current month | +6.19% | ||
1 month | -66.51% | ||
3 months | -76.22% | ||
6 months | -79.23% | ||
Current year | -85.50% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Huseby
CEO | Chief Executive Officer | 69 | 13-12-31 |
Kevin Watson
DFI | Director of Finance/CFO | 57 | 23-09-06 |
Stephen Culver
CTO | Chief Tech/Sci/R&D Officer | 59 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Huseby
CEO | Chief Executive Officer | 69 | 13-12-31 |
David Golden
BRD | Director/Board Member | 66 | 15-08-01 |
John Ryan
CHM | Chairman | 79 | 15-07-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 0.216 | +3.10% | 648,376 |
24-05-01 | 0.2095 | +3.00% | 820,747 |
24-04-30 | 0.2034 | +1.70% | 545,770 |
24-04-29 | 0.2 | +0.55% | 664,474 |
24-04-26 | 0.1989 | -4.14% | 2,707,801 |
Delayed Quote Nyse, May 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.50% | 11.48M | |
-18.14% | 1.77B | |
+50.44% | 220M | |
+54.30% | 69.02M |
- Stock Market
- Equities
- BNED Stock